FOLH1 and prostate carcinoma: DOX-encapsulating aptamosomes showed enhanced prostate cancer cell (PSMA positive) binding and uptake in vitro and, most importantly, was selectively retained in tumor tissue in vivo leading to reduced tumor size in xenograft mice.